OGN Jan 2025 7.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:04PM EDT. Market open.
| Previous close | 8.70 |
| Open | 8.80 |
| Bid | 9.50 |
| Ask | 10.90 |
| Strike | 7.50 |
| Expiry date | 2025-01-17 |
| Day's range | 8.70 - 8.80 |
| Contract range | N/A |
| Volume | |
| Open interest | 2 |
GlobeNewswireOrganon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
VTAMA cream is a novel, non-steroidal topical therapy approved for treatment of plaque psoriasis in adults and is under FDA review for an additional indication to treat atopic dermatitis Proposed acquisition extends Organon’s international dermatology capabilities to the U.S. BASEL, Switzerland and LONDON and NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of women throughout their lives, and Dermavant Sciences Lt
ZacksShould WisdomTree U.S. SmallCap Dividend ETF (DES) Be on Your Investing Radar?
Style Box ETF report for DES
Business WireOrganon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets
JERSEY CITY, N.J., August 20, 2024--Organon & Lilly expand migraine commercialization agreement to 11 more markets
© 2024 Yahoo. All rights reserved.